LLY compared with AQST: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

AQSTAquestive Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

AQSTAquestive Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only AQST 12

INDVIndiviorcustomer

—Licenseesunlistedcustomer

—RTW Investmentsunlistedcustomer

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Sunovion

unlistedcustomer

8 more · AQST chain ›

LLYELI Lilly & Co

1,371.32· pre 1,345.00· delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

AQSTAquestive Therapeutics, Inc.

3.64· pre 3.64· delayed

Pre-marketNov 6 '26delayed

Mkt cap$460.0MRevenue$8MQ3 FY26Revenue$45MFY25

Compare

Pre-marketNov 6 '26delayed

LLYELI Lilly & Co

AQSTAquestive Therapeutics, Inc.

1,371.32pre 1,345.00delayed

Price

3.64pre 3.64delayed

$1.2T

Mkt cap

$460.0M

Q3 FY26$24.4B

Revenue

$8MQ3 FY26

FY25$65.2B

Revenue

$45MFY25

LLY1,371.32vsAQST3.64Pre-marketNov 6 '26delayed